Javier Castañeda

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

Yves Reznik, Ohad Cohen, Ronnie Aronson et al. · The Lancet · 2014 · 231 citations

Medicine, Endocrinology, Diabetology +12

Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users

Julien Da Silva, Giuseppe Lepore, Tadej Battelino et al. · Diabetes Technology & Therapeutics · 2021 · 218 citations · Full text

Medicine, Health Informatics, Clinical Decision Support +14

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

Pratik Choudhary, Ralf Kolassa, Winfried Keuthage et al. · The Lancet Diabetes & Endocrinology · 2022 · 187 citations · Full text

Medicine, Endocrinology, Internal Medicine +9

Comparison of <scp>MiniMed 780G</scp> system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users

Arcelia Arrieta, Tadej Battelino, Andrea Scaramuzza et al. · Diabetes Obesity and Metabolism · 2022 · 149 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

Emanuele Bosi, Pratik Choudhary, Harold W. de Valk et al. · The Lancet Diabetes & Endocrinology · 2019 · 123 citations

Medicine, Endocrinology, Diabetology +13